GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Gene Bio Tech Co Ltd (XKRX:086060) » Definitions » Change In Receivables

Gene Bio Tech Co (XKRX:086060) Change In Receivables : ₩156 Mil (TTM As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Gene Bio Tech Co Change In Receivables?

Gene Bio Tech Co's change in receivables for the quarter that ended in Jun. 2024 was ₩-879 Mil. It means Gene Bio Tech Co's Accounts Receivable increased by ₩879 Mil from Mar. 2024 to Jun. 2024 .

Gene Bio Tech Co's change in receivables for the fiscal year that ended in Dec. 2023 was ₩2,556 Mil. It means Gene Bio Tech Co's Accounts Receivable declined by ₩2,556 Mil from Dec. 2022 to Dec. 2023 .

Gene Bio Tech Co's Accounts Receivable for the quarter that ended in Jun. 2024 was ₩12,711 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Gene Bio Tech Co's Days Sales Outstanding for the three months ended in Jun. 2024 was 57.02.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Gene Bio Tech Co's liquidation value for the three months ended in Jun. 2024 was ₩20,511 Mil.


Gene Bio Tech Co Change In Receivables Historical Data

The historical data trend for Gene Bio Tech Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gene Bio Tech Co Change In Receivables Chart

Gene Bio Tech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 989.27 503.08 -3,633.91 -4,025.41 2,556.21

Gene Bio Tech Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -646.50 -440.51 1,746.81 -271.29 -879.48

Gene Bio Tech Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩156 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gene Bio Tech Co  (XKRX:086060) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Gene Bio Tech Co's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=12711.489/20344.16*91
=57.02

2. In Ben Graham's calculation of liquidation value, Gene Bio Tech Co's accounts receivable are only considered to be worth 75% of book value:

Gene Bio Tech Co's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=23369.071-21053.549+0.75 * 12711.489+0.5 * 17323.756
=20,511

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gene Bio Tech Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Gene Bio Tech Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Gene Bio Tech Co Business Description

Traded in Other Exchanges
N/A
Address
311-3, Gyeongcheon-Ri, Gyeryong-Myeon, Gongju, KOR, 314-831
Gene Bio Tech Co Ltd is a specialized fermentation company which researches, develops, produces, and sells biological resources for use in animal resources, agriculture, food and medicine. It offers functional feed ingredients and additives.

Gene Bio Tech Co Headlines

No Headlines